A crucial determinant for the success of intensive insulin therapy in critically ill patients is the frequent and accurate measurement of blood glucose values with immediate feedback of results. In general, therefore, this is achieved by point-of-care testing, raising the question of the best way of monitoring blood glucose. Corstjens and coworkers, in the previous issue of Critical Care, demonstrate that, in spite of good correlation to "conventional" laboratory glucose assessment, absolute glucose levels may differ systematically. This commentary reviews the problems of glucose measurements arising from matrix effects, interferences and the use of different assays.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794478 | PMC |
http://dx.doi.org/10.1186/cc5110 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!